Iron deficiency

3 trials 2 recruiting MedDRA PT
3 Registered trials
2 Recruiting
3 Unique sponsors
5 Unique IMPs
2 Commercial trials
Drug classes (ATC)
B Haematology (ATC B) 3
Mechanism of action (INN-stem analysis)
Unknown / small molecule 4 substances
Supportive / diluent 1 substance
Phase III: 1 Phase III/IV: 1 Phase IV: 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

1 trial
  • Pharmacosmos A/S Commercial
    FERRIC DERISOMALTOSE
    2024-519059-28-00 12 countries 2025 n=950
    Recruiting

Phase III/IV

1 trial
  • Pharmanutra S.p.A. Commercial
    FERRIC MALTOL
    2025-522004-24-00 1 country 2025 n=146
    Recruiting

Phase IV

1 trial
  • Wroclaw Medical University Academic
    DRIED FERROUS SULFATE; FERRIC CARBOXYMALTOSE; SODIUM CHLORIDE
    2025-521570-34-00 1 country n=396
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Pharmanutra S.p.A. Commercial 1 Phase III/IV 1
Pharmacosmos A/S Commercial 1 Phase III 1
Wroclaw Medical University Academic 1 Phase IV 0
New trials by year
2025
2
← All indication landscapes